MDPI and ACS Style
Sato, M.; Fujita, H.; Yokoyama, H.; Mikada, A.; Horikawa, Y.; Takahashi, Y.; Yamada, Y.; Waki, H.; Narita, T.
Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study. J. Clin. Med. 2023, 12, 3104.
https://doi.org/10.3390/jcm12093104
AMA Style
Sato M, Fujita H, Yokoyama H, Mikada A, Horikawa Y, Takahashi Y, Yamada Y, Waki H, Narita T.
Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study. Journal of Clinical Medicine. 2023; 12(9):3104.
https://doi.org/10.3390/jcm12093104
Chicago/Turabian Style
Sato, Masahiro, Hiroki Fujita, Hiroki Yokoyama, Atsushi Mikada, Yohei Horikawa, Yuya Takahashi, Yuichiro Yamada, Hironori Waki, and Takuma Narita.
2023. "Relationships among Postprandial Plasma Active GLP-1 and GIP Excursions, Skeletal Muscle Mass, and Body Fat Mass in Patients with Type 2 Diabetes Treated with Either Miglitol, Sitagliptin, or Their Combination: A Secondary Analysis of the MASTER Study" Journal of Clinical Medicine 12, no. 9: 3104.
https://doi.org/10.3390/jcm12093104
